BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 26221185)

  • 21. Differentially expressed genes are marked by histone 3 lysine 9 trimethylation in human cancer cells.
    Wiencke JK; Zheng S; Morrison Z; Yeh RF
    Oncogene; 2008 Apr; 27(17):2412-21. PubMed ID: 17968314
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An epigenomic role of Fe65 in the cellular response to DNA damage.
    Ryu S; Teles F; Minopoli G; Russo T; Rosenfeld MG; Suh Y
    Mutat Res; 2015 Jun; 776():40-7. PubMed ID: 26255939
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stably paused genes revealed through inhibition of transcription initiation by the TFIIH inhibitor triptolide.
    Chen F; Gao X; Shilatifard A
    Genes Dev; 2015 Jan; 29(1):39-47. PubMed ID: 25561494
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Predicting distinct organization of transcription factor binding sites on the promoter regions: a new genome-based approach to expand human embryonic stem cell regulatory network.
    Hosseinpour B; Bakhtiarizadeh MR; Khosravi P; Ebrahimie E
    Gene; 2013 Dec; 531(2):212-9. PubMed ID: 24042128
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regulation of human prostate-specific G-protein coupled receptor, PSGR, by two distinct promoters and growth factors.
    Weng J; Ma W; Mitchell D; Zhang J; Liu M
    J Cell Biochem; 2005 Dec; 96(5):1034-48. PubMed ID: 16149059
    [TBL] [Abstract][Full Text] [Related]  

  • 26. ChIP-on-chip analysis of in vivo mutant p53 binding to selected gene promoters.
    Dell'Orso S; Fontemaggi G; Stambolsky P; Goeman F; Voellenkle C; Levrero M; Strano S; Rotter V; Oren M; Blandino G
    OMICS; 2011 May; 15(5):305-12. PubMed ID: 21332394
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential DNA repair underlies mutation hotspots at active promoters in cancer genomes.
    Perera D; Poulos RC; Shah A; Beck D; Pimanda JE; Wong JW
    Nature; 2016 Apr; 532(7598):259-63. PubMed ID: 27075100
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The histone variant H2A.Z is an important regulator of enhancer activity.
    Brunelle M; Nordell Markovits A; Rodrigue S; Lupien M; Jacques PÉ; Gévry N
    Nucleic Acids Res; 2015 Nov; 43(20):9742-56. PubMed ID: 26319018
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Histone demethylase RBP2 promotes lung tumorigenesis and cancer metastasis.
    Teng YC; Lee CF; Li YS; Chen YR; Hsiao PW; Chan MY; Lin FM; Huang HD; Chen YT; Jeng YM; Hsu CH; Yan Q; Tsai MD; Juan LJ
    Cancer Res; 2013 Aug; 73(15):4711-21. PubMed ID: 23722541
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Unraveling a connection between DNA demethylation repair and cancer.
    Camps M; Eichman BF
    Mol Cell; 2011 Nov; 44(3):343-4. PubMed ID: 22055180
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Erratum: ALKBH3 is dispensable in maintaining hematopoietic stem cells but forced ALKBH3 rectified the differentiation skewing of aged hematopoietic stem cells.
    Blood Sci; 2021 Jul; 3(3):104. PubMed ID: 35404001
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Global SUMOylation on active chromatin is an acute heat stress response restricting transcription.
    Niskanen EA; Malinen M; Sutinen P; Toropainen S; Paakinaho V; Vihervaara A; Joutsen J; Kaikkonen MU; Sistonen L; Palvimo JJ
    Genome Biol; 2015 Jul; 16(1):153. PubMed ID: 26259101
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fluorescence Monitoring of the Oxidative Repair of DNA Alkylation Damage by ALKBH3, a Prostate Cancer Marker.
    Beharry AA; Lacoste S; O'Connor TR; Kool ET
    J Am Chem Soc; 2016 Mar; 138(11):3647-50. PubMed ID: 26967262
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rhein Inhibits AlkB Repair Enzymes and Sensitizes Cells to Methylated DNA Damage.
    Li Q; Huang Y; Liu X; Gan J; Chen H; Yang CG
    J Biol Chem; 2016 May; 291(21):11083-93. PubMed ID: 27015802
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transcriptome-wide mapping reveals reversible and dynamic N(1)-methyladenosine methylome.
    Li X; Xiong X; Wang K; Wang L; Shu X; Ma S; Yi C
    Nat Chem Biol; 2016 May; 12(5):311-6. PubMed ID: 26863410
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CpG promoter methylation of the ALKBH3 alkylation repair gene in breast cancer.
    Stefansson OA; Hermanowicz S; van der Horst J; Hilmarsdottir H; Staszczak Z; Jonasson JG; Tryggvadottir L; Gudjonsson T; Sigurdsson S
    BMC Cancer; 2017 Jul; 17(1):469. PubMed ID: 28679371
    [TBL] [Abstract][Full Text] [Related]  

  • 37. AlkB homolog 3-mediated tRNA demethylation promotes protein synthesis in cancer cells.
    Ueda Y; Ooshio I; Fusamae Y; Kitae K; Kawaguchi M; Jingushi K; Hase H; Harada K; Hirata K; Tsujikawa K
    Sci Rep; 2017 Feb; 7():42271. PubMed ID: 28205560
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transfer RNA demethylase ALKBH3 promotes cancer progression via induction of tRNA-derived small RNAs.
    Chen Z; Qi M; Shen B; Luo G; Wu Y; Li J; Lu Z; Zheng Z; Dai Q; Wang H
    Nucleic Acids Res; 2019 Mar; 47(5):2533-2545. PubMed ID: 30541109
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dynamic RNA Modifications in Gene Expression Regulation.
    Roundtree IA; Evans ME; Pan T; He C
    Cell; 2017 Jun; 169(7):1187-1200. PubMed ID: 28622506
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epigenetic loss of m1A RNA demethylase ALKBH3 in Hodgkin lymphoma targets collagen, conferring poor clinical outcome.
    Esteve-Puig R; Climent F; Piñeyro D; Domingo-Domènech E; Davalos V; Encuentra M; Rea A; Espejo-Herrera N; Soler M; Lopez M; Ortiz-Barahona V; Tapia G; Navarro JT; Cid J; Farré L; Villanueva A; Casanova I; Mangues R; Santamarina-Ojeda P; Fernández AF; Fraga MF; Piris MA; Kol N; Avrahami C; Moshitch-Moshkovitz S; Rechavi G; Sureda A; Esteller M
    Blood; 2021 Feb; 137(7):994-999. PubMed ID: 32915956
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.